OTCQX:MRVFF - Post by User
Comment by
JohnDDon May 09, 2013 8:43am
102 Views
Post# 21356163
RE: European Patent for Pennsaid 2% a done deal.
RE: European Patent for Pennsaid 2% a done deal. Where are they going to get the funds to undertake phase III clinical trials in order to get approval in these other jurisdictions. In recent MD&A's they indicate that this cost is estimated at $30-40 million. Coviden/Mallencroft was supposed to complete the phase III trials as part of the US distribution agreementl, but as we know they never did. What is Nuvo Management going to do about it?
John